CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Operating Activities
Net earnings	$ 515,217	$ 347,730
Adjustments to reconcile net earnings to cash from operating activities:
Depreciation and amortization	293,880	263,421
Stock-based compensation expense	21,810	17,791
Gain on sale of assets	(1,214)	(3,466)
Gain on sale of businesses	(90,093)	(11,228)
Cash effect of changes in assets and liabilities (excluding effects of acquisitions, dispositions and foreign exchange):
Accounts receivable, net	(127,004)	(31,791)
Inventories	(92,853)	(21,223)
Prepaid expenses and other assets	(7,534)	(15,932)
Accounts payable	103,926	38,582
Accrued compensation and employee benefits	8,008	(15,999)
Accrued expenses and other liabilities	(41,136)	23,076
Accrued and deferred taxes, net	(51,106)	8,565
Other, net	(29,936)	(26,580)
Net cash provided by operating activities	501,965	572,946
Investing Activities
Additions to property, plant and equipment	(150,149)	(115,768)
Acquisitions, net of cash and cash equivalents acquired	(25,568)	(501,828)
Proceeds from sale of property, plant and equipment	8,606	9,971
Proceeds from sale of businesses	121,175	47,300
Other	21,151	(1,057)
Net cash used in investing activities	(24,785)	(561,382)
Financing Activities
Proceeds and Excess Tax Benefits from Share-based Compensation	0	6,828
Change in commercial paper and notes payable	(279,927)	355,275
Dividends paid to stockholders	(210,549)	(199,759)
Payments to settle employee tax obligations on exercise of share-based awards	(13,812)	(13,024)
Other	(2,912)	0
Net cash (used in) provided by financing activities	(507,200)	149,320
Cash Flows
Effect of exchange rate changes on cash and cash equivalents	2,913	(8,314)
Net (decrease) increase in cash and cash equivalents	(27,107)	152,570
Cash and cash equivalents at beginning of period	349,146	362,185
Cash and cash equivalents at end of period	$ 322,039	$ 514,755